Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Charles Nault

Showing results (51-60 of 179) with videos related to

Pageof 18
Sort By:
BMC Cancer|January 8, 2014
Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinomaAdeodat Ilboudo, Jean-Charles Nault, Hélène Dubois-Pot-Schneider, et al.
Clinics and Research in Hepatology and Gastroenterology|November 16, 2024
Prolonged survival in women with hepatocellular carcinoma: A French observational studyCécilia Busso, Jean-Charles Nault, Richard Layese, et al.
JHEP Reports : Innovation in Hepatology|July 10, 2023
Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002-2022)Sabrina Sidali, Nanthara Sritharan, Claudia Campani, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2026
Second-Line TKI after First-Line Immunotherapy-based Treatment in Advanced HCC: Reconstructed IPD Meta-analysisErman Akkus, Christian Hobeika, Julien Edeline, et al.
Molecular Therapy. Methods & Clinical Development|September 17, 2024
Predictive power of deleterious single amino acid changes to infer on AAV2 and AAV2-13 capsids fitnessTiziana La Bella, Bérangère Bertin, Ante Mihaljevic, et al.
Journal of Liver Cancer|March 10, 2025
Insights into hepatocellular adenomas in Asia: molecular subtypes, clinical characteristics, imaging features, and hepatocellular carcinoma risksSubin Heo, In Hye Song, Edouard Reizine, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosisJean Charles Nault, Julien Calderaro, Luca Di Tommaso, et al.
European Radiology|February 9, 2024
Incidence and clinical impact of bile ducts changes after multibipolar radiofrequency ablation for hepatocellular carcinomaEloi Varin, Paul Beunon, Gisèle N'Kontchou, et al.
Future Oncology (London, England)|January 19, 2016
The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, et al.
Hepatology (Baltimore, Md.)|March 25, 2018
Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomasJean-Charles Nault, Gabrielle Couchy, Stefano Caruso, et al.
Pageof 18

Showing results (51-60 of 179) with videos related to

Sort By:
Pageof 18
BMC Cancer|January 8, 2014
Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinomaAdeodat Ilboudo, Jean-Charles Nault, Hélène Dubois-Pot-Schneider, et al.
Clinics and Research in Hepatology and Gastroenterology|November 16, 2024
Prolonged survival in women with hepatocellular carcinoma: A French observational studyCécilia Busso, Jean-Charles Nault, Richard Layese, et al.
JHEP Reports : Innovation in Hepatology|July 10, 2023
Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002-2022)Sabrina Sidali, Nanthara Sritharan, Claudia Campani, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2026
Second-Line TKI after First-Line Immunotherapy-based Treatment in Advanced HCC: Reconstructed IPD Meta-analysisErman Akkus, Christian Hobeika, Julien Edeline, et al.
Molecular Therapy. Methods & Clinical Development|September 17, 2024
Predictive power of deleterious single amino acid changes to infer on AAV2 and AAV2-13 capsids fitnessTiziana La Bella, Bérangère Bertin, Ante Mihaljevic, et al.
Journal of Liver Cancer|March 10, 2025
Insights into hepatocellular adenomas in Asia: molecular subtypes, clinical characteristics, imaging features, and hepatocellular carcinoma risksSubin Heo, In Hye Song, Edouard Reizine, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosisJean Charles Nault, Julien Calderaro, Luca Di Tommaso, et al.
European Radiology|February 9, 2024
Incidence and clinical impact of bile ducts changes after multibipolar radiofrequency ablation for hepatocellular carcinomaEloi Varin, Paul Beunon, Gisèle N'Kontchou, et al.
Future Oncology (London, England)|January 19, 2016
The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, et al.
Hepatology (Baltimore, Md.)|March 25, 2018
Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomasJean-Charles Nault, Gabrielle Couchy, Stefano Caruso, et al.
Pageof 18